News for Salix Pharmaceuticals, Ltd. - Google Finance

Salix Pharma To Present At Wells Fargo Healthcare Conference; Webcast At 1 ...

Tue, 18 Jun 2013 17:00:20 GMT

Salix Pharma To Present At Wells Fargo Healthcare Conference; Webcast At 1 ...
NASDAQ - Jun 18, 2013

loading. (RTTNews.com) - Salix Pharmaceuticals Ltd ( SLXP ) will present at the Wells Fargo Healthcare Conference in Boston, MA.

Salix Pharmaceuticals Upgraded by Zacks to "Outperform" (SLXP)

Wed, 19 Jun 2013 18:22:32 GMT

Salix Pharmaceuticals Upgraded by Zacks to "Outperform" (SLXP)
Daily Political - 9 hours ago

Salix Pharmaceuticals, Ltd. logo Salix Pharmaceuticals (NASDAQ: SLXP) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research report issued on Wednesday, Analyst Ratings Network reports.

Salix Pharmaceuticals PT Raised to $85.00 (SLXP) - Zolmax

Is Salix Pharmaceuticals, Ltd. (SLXP) Going to Burn These Hedge Funds?

Thu, 30 May 2013 12:50:57 GMT

Is Salix Pharmaceuticals, Ltd. (SLXP) Going to Burn These Hedge Funds?
Insider Monkey (blog) - May 30, 2013

Is Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) worth your attention right now? The best stock pickers are becoming less hopeful.

SALIX PHARMACEUTICALS, LTD. : Salix Pharmaceuticals to Present at Two ... - 4-traders (press release)
Salix Pharmaceuticals Given Buy Rating at Jefferies Group (SLXP) - Watch List News (press release)

SALIX PHARMACEUTICALS, LTD. : Salix and Progenics Announce FDA ...

Tue, 11 Jun 2013 14:51:23 GMT

SALIX PHARMACEUTICALS, LTD. : Salix and Progenics Announce FDA ...
4-traders (press release) - Jun 11, 2013

RALEIGH, NC and TARRYTOWN, NY, June 11, 2013 - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals (NASDAQ:PGNX) today announced that the FDA is seeking input from an Advisory Committee on Salix's Supplemental New ...

Salix Pharmaceuticals Given "Buy" Rating at Jefferies Group (SLXP) - The Utah People's Post
Salix and Progenics Announce FDA Advisory Committee to Review Relistor ... - DailyFinance

SALIX PHARMACEUTICALS, LTD. : New Breakthroughs Allow Companies to ...

Thu, 06 Jun 2013 12:08:51 GMT

SALIX PHARMACEUTICALS, LTD. : New Breakthroughs Allow Companies to ...
4-traders (press release) - Jun 6, 2013

Today, Wall Street Reports announced new research reports highlighting Perrigo Company (NASDAQ: PRGO), Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), Actavis Inc. (NYSE: ACT), Mylan, Inc. (NASDAQ: MYL), and Salix Pharmaceuticals, Ltd.

Salix Pharma Says Results for Budesonide Foam Statistically Significant

Wed, 22 May 2013 11:29:43 GMT

Salix Pharma Says Results for Budesonide Foam Statistically Significant
Benzinga - May 22, 2013

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced the successful completion and outcome of two pivotal Phase 3 studies to evaluate the efficacy and safety of budesonide foam in the treatment of active mild to moderate ulcerative proctitis (UP ...

Salix rectal inflammation drug shows positive clinical trial results - WRAL Tech Wire
Salix reports successful Phase 3 for colitis candidate - Triangle Business Journal

Salix Pharmaceuticals Rating Increased to Buy at Buckingham Research (SLXP)

Thu, 13 Jun 2013 11:50:26 GMT

Salix Pharmaceuticals Rating Increased to Buy at Buckingham Research (SLXP)
Watch List News (press release) - Jun 13, 2013

Salix Pharmaceuticals, Ltd. logo Salix Pharmaceuticals (NASDAQ: SLXP) was upgraded by analysts at Buckingham Research from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, TheFlyOnTheWall.

The Zacks Analyst Blog Highlights: Eli Lilly, Teva, Salix Pharmaceuticals ...

Wed, 05 Jun 2013 13:38:19 GMT

The Zacks Analyst Blog Highlights: Eli Lilly, Teva, Salix Pharmaceuticals ...
Wall Street Journal (press release) - Jun 5, 2013

... stocks and the financial markets. Stocks recently featured in the blog include Eli Lilly and Company (NYSE:LLY), Teva (NYSE:TEVA), Salix Pharmaceuticals Ltd. (Nasdaq:SLXP), Santarus, Inc. (Nasdaq:SNTS) and Turkcell Iletisim Hizmetleri AS (NYSE:TKC).

Salix Pharmaceuticals Upgraded to “Buy” by Buckingham Research (SLXP)

Fri, 14 Jun 2013 12:50:42 GMT

Salix Pharmaceuticals Upgraded to “Buy” by Buckingham Research (SLXP)
Ticker Report - Jun 14, 2013

Salix Pharmaceuticals, Ltd. logo Buckingham Research upgraded shares of Salix Pharmaceuticals (NASDAQ: SLXP) from a neutral rating to a buy rating in a research report released on Wednesday morning, TheFlyOnTheWall.

Positive Data from Synergy Pharma - Analyst Blog

Fri, 24 May 2013 16:37:18 GMT

Positive Data from Synergy Pharma - Analyst Blog
NASDAQ - May 24, 2013

The constipation market already includes Ironwood Pharmaceuticals/ Forest Laboratories' ( IRWD / FRX ) Linzess for treating adults suffering from IBS-C or CIC.